Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Burkart, Sebastian [VerfasserIn]   i
 Weusthof, Christopher [VerfasserIn]   i
 Khorani, Karam [VerfasserIn]   i
 Steen, Sonja [VerfasserIn]   i
 Stögbauer, Fabian [VerfasserIn]   i
 Unger, Kristian [VerfasserIn]   i
 Hess, Julia [VerfasserIn]   i
 Zitzelsberger, Horst [VerfasserIn]   i
 Belka, Claus [VerfasserIn]   i
 Kurth, Ina [VerfasserIn]   i
 Heß, Jochen [VerfasserIn]   i
Titel:A novel subgroup of UCHL1-related cancers is associated with genomic instability and sensitivity to DNA-damaging treatment
Verf.angabe:Sebastian Burkart, Christopher Weusthof, Karam Khorani, Sonja Steen, Fabian Stögbauer, Kristian Unger, Julia Hess, Horst Zitzelsberger, Claus Belka, Ina Kurth and Jochen Hess
E-Jahr:2023
Jahr:8 March 2023
Umfang:16 S.
Fussnoten:Gesehen am 24.04.2023
Titel Quelle:Enthalten in: Cancers
Ort Quelle:Basel : MDPI, 2009
Jahr Quelle:2023
Band/Heft Quelle:15(2023), 6 vom: März, Artikel-ID 1655, Seite 1-16
ISSN Quelle:2072-6694
Abstract:Purpose: Identification of molecularly-defined cancer subgroups and targeting tumor-specific vulnerabilities have a strong potential to improve treatment response and patient outcomes but remain an unmet challenge of high clinical relevance, especially in head and neck squamous cell carcinoma (HNSC). Experimental design: We established a UCHL1-related gene set to identify and molecularly characterize a UCHL1-related subgroup within TCGA-HNSC by integrative analysis of multi-omics data. An extreme gradient boosting model was trained on TCGA-HNSC based on GSVA scores for gene sets of the MSigDB to robustly predict UCHL1-related cancers in other solid tumors and cancer cell lines derived thereof. Potential vulnerabilities of UCHL1-related cancer cells were elucidated by an in-silico drug screening approach. Results: We established a 497-gene set, which stratified the TCGA-HNSC cohort into distinct subgroups with a UCHL1-related or other phenotype. UCHL1-related HNSC were characterized by higher frequencies of genomic alterations, which was also evident for UCHL1-related cancers of other solid tumors predicted by the classification model. These data indicated an impaired maintenance of genomic integrity and vulnerability for DNA-damaging treatment, which was supported by a favorable prognosis of UCHL1-related tumors after radiotherapy, and a higher sensitivity of UCHL1-related cancer cells to irradiation or DNA-damaging compounds (e.g., Oxaliplatin). Conclusion: Our study established UCHL1-related cancers as a novel subgroup across most solid tumor entities with a unique molecular phenotype and DNA-damaging treatment as a specific vulnerability, which requires further proof-of-concept in pre-clinical models and future clinical trials.
DOI:doi:10.3390/cancers15061655
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.3390/cancers15061655
 Volltext: https://www.mdpi.com/2072-6694/15/6/1655
 DOI: https://doi.org/10.3390/cancers15061655
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:head and neck squamous cell carcinoma (HNSC
 HNSCC)
 integrative multi-omics analysis
 pan-cancer
 radiotherapy
 ubiquitin C-terminal hydrolase L1
K10plus-PPN:1843420252
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69068394   QR-Code
zum Seitenanfang